We also showed that GLUT1-STn overexpression may hold potential for ESCC patient stratification, enabling the identification of subgroups facing worst prognosis, as previously suggested when the two antigens were evaluated separately. Here, SLC2A1 is linked to esophageal squamous cell carcinoma.